Text this: Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study

 _____     __   __   _    _     _____    _    _   
|  __ \\   \ \\/ // | || | ||  |  ___|| | || | || 
| |  \ ||   \ ` //  | || | ||  | ||__   | || | || 
| |__/ ||    | ||   | \\_/ ||  | ||__   | \\_/ || 
|_____//     |_||    \____//   |_____||  \____//  
 -----`      `-`'     `---`    `-----`    `---`